Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cancer Related Cognitive Decline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8972 Neoplasms 6886 Carcinoma, Non-Small-Cell Lung 5045 Prostatic Neoplasms 4451 Colorectal Neoplasms 4030 Lung Neoplasms 3262 Leukemia, Myeloid, Acute 2718 Neoplasm Metastasis 2709 Multiple Myeloma 2700 Pancreatic Neoplasms 2516 Melanoma 2342 Lymphoma 2288 Ovarian Neoplasms 2266 Carcinoma, Hepatocellular 2180 Stomach Neoplasms 2063 Recurrence 1950 Head and Neck Neoplasms 1837 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1824 Lymphoma, Non-Hodgkin 1810 Leukemia 1800 Brain Neoplasms 1709 Glioblastoma 1603 Colonic Neoplasms 1573 Leukemia, Lymphocytic, Chronic, B-Cell 1546 Rectal Neoplasms 1513 Uterine Cervical Neoplasms 1462 Lymphoma, Follicular 1436 Squamous Cell Carcinoma of Head and Neck 1432 Lymphoma, Large B-Cell, Diffuse 1400 Carcinoma, Renal Cell 1376

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡